Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.470
-0.020 (-0.57%)
At close: Aug 7, 2026, 4:00 PM EDT
3.530
+0.060 (1.73%)
Pre-market: Aug 10, 2026, 8:13 AM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $13.24 million as of August 10, 2026. Its market cap has increased by 454.83% in one year.
Market Cap
13.24M
Enterprise Value
5.79M
1-Year Change
454.83%
Ranking
Category
Stock Price
$3.47
ChartMarket Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $13.24M, a decrease of -95.91%. That is a compound annual growth rate of -49.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 13.24M | 838.44% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 14.96M |
| Tempest Therapeutics | 14.65M |
| Passage Bio | 14.11M |
| Palatin Technologies | 14.02M |
| KALA BIO | 13.90M |
| Chemomab Therapeutics | 13.90M |
| SeaStar Medical Holding | 13.19M |
| BioLineRx | 13.11M |